Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a grant opportunity from the National Institutes of Health (NIH) focused on developing new therapies for glioblastoma. It's designed for researchers and organizations working on clinical trials to advance treatments for this type of aggressive brain cancer.
Eligibility Requirements
Application Guide
Likely based on scientific merit, feasibility of the clinical trial, potential impact on glioblastoma treatment, and investigator qualifications.
Focus on a robust clinical trial design and clearly articulate the potential for significant advancements in glioblastoma therapy. Highlight team expertise in both glioblastoma and clinical research.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 9/13/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.
View all opportunities from HHS-NIH11
Run this program? Claim this listing · Report a correction